undamentalytics Newsletter
Sign in

Volitionrx LTD revenue

Volitionrx LTD's revenue was $1.7m in fiscal 2025, up 40.0% on the year before. Since fiscal 2012 ($54,968) it has grown at a compound 53.9% a year. Over the last twelve months it was $2.5m.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20112012Dec 20122014Dec 20142019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue055151713903067751,2341,7272,458
Growth on the year before——−73.1%+15.6%−21.4%+570.3%+240.3%+153.0%+59.1%+40.0%—

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Volitionrx LTD $2.5m 86.3% 68.0%
Femasys Inc $2.3m 21.9% 24.3%
Icecure Medical Ltd. $3.4m 2.7% —
Seastar Medical Holding Corp $1.7m 123.6% —
Insight Molecular Diagnostics Inc. $1.7m -60.8% 14.9%
Cerenome, Inc. $4.2m -21.0% 16.1%

Compare with peers

Head to head: FEMY vs VNRXICCM vs VNRXICU vs VNRX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Volitionrx LTD's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Volitionrx LTD.